Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01409902 · ClinicalTrials.gov registry record
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 38
- Enrollment target
NCT01409902: Completed study, sponsored by University of South Florida.
NCT01409902 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01409902 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The main objective of the study is to assess the effectiveness of the sheathed speculum in providing adequate visualization and access to the cervix in patients with excessive vaginal tissue. The secondary objective is to rate the patient's comfort evaluation during the sheathed speculum examination.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-03 |
What the finished NCT01409902 record still lists
NCT01409902 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01409902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01409902 about?
NCT01409902 is a clinical study titled "Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue". The main objective of the study is to assess the effectiveness of the sheathed speculum in providing adequate visualization and access to the cervix in patients with excessive vaginal tissue. The secondary objective is to rate the patient's comfort evaluation during the sheathed speculum examinatio...
What is the current status of trial NCT01409902?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2008-06. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT01409902?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia